CDK8 and neoplasm: Although SNX631 did not affect in vitro proliferation (Fig. 2A) or in vivo primary tumor growth of murine 4T1 cells (Fig. 3H), CDK8/19i were previously shown to selectively affect the metastatic over the primary tumors in colon cancer (12).